ZA200200106B - Orally active androgens. - Google Patents
Orally active androgens.Info
- Publication number
- ZA200200106B ZA200200106B ZA200200106A ZA200200106A ZA200200106B ZA 200200106 B ZA200200106 B ZA 200200106B ZA 200200106 A ZA200200106 A ZA 200200106A ZA 200200106 A ZA200200106 A ZA 200200106A ZA 200200106 B ZA200200106 B ZA 200200106B
- Authority
- ZA
- South Africa
- Prior art keywords
- orally active
- active androgens
- androgens
- orally
- active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99202348 | 1999-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200200106B true ZA200200106B (en) | 2003-06-25 |
Family
ID=8240463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200200106A ZA200200106B (en) | 1999-07-16 | 2002-01-04 | Orally active androgens. |
Country Status (28)
Country | Link |
---|---|
US (3) | US6313108B1 (de) |
EP (1) | EP1203011B1 (de) |
JP (1) | JP2003505394A (de) |
KR (1) | KR20020092890A (de) |
CN (1) | CN1360589A (de) |
AR (1) | AR024746A1 (de) |
AT (1) | ATE257159T1 (de) |
AU (1) | AU770412B2 (de) |
BR (1) | BR0012489A (de) |
CA (1) | CA2379223A1 (de) |
CO (1) | CO5200765A1 (de) |
CZ (1) | CZ2002192A3 (de) |
DE (1) | DE60007530T2 (de) |
ES (1) | ES2213596T3 (de) |
HK (1) | HK1043797A1 (de) |
HU (1) | HUP0201952A3 (de) |
IL (1) | IL147332A0 (de) |
MX (1) | MXPA02000601A (de) |
NO (1) | NO20020222L (de) |
NZ (1) | NZ516525A (de) |
PE (1) | PE20010330A1 (de) |
PL (1) | PL353007A1 (de) |
RU (1) | RU2002103883A (de) |
SK (1) | SK712002A3 (de) |
TR (1) | TR200200076T2 (de) |
TW (1) | TW548277B (de) |
WO (1) | WO2001005806A1 (de) |
ZA (1) | ZA200200106B (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2204613T3 (es) * | 1999-04-06 | 2004-05-01 | Akzo Nobel N.V. | Androgenos 7-alfa alquilo oralmente activos. |
AU4966101A (en) * | 2000-03-31 | 2001-10-15 | Us Gov Health & Human Serv | Methods of making and using 7alpha,11beta-dimethyl-17beta-hydroxy-4-estren-3-one17beta-trans-4-m-butylcyclohexane carboxylate and 7alpha,11beta-dimethyl-17beta -hydroxyestr-4-en-3-one 17-undecanoate |
US20030069215A1 (en) * | 2001-03-30 | 2003-04-10 | The Government Of The United States Of America, | Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate |
BR0112791A (pt) * | 2000-07-28 | 2003-06-24 | Akzo Nobel Nv | Composto esteroidal 16alfa-substituido, uso do mesmo, métodos de tratamento para ativação seletiva de receptores de estrogênio do subtipo alfa, e para terapia de reposição hormonal ou contracepção, e, composição farmacêutica |
ES2261665T3 (es) * | 2001-03-30 | 2006-11-16 | The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | Procedimientos de fabricacion y formulaciones farmaceuticas que comprenden 7alfa, 11beta-dimetil-17beta-hidroxiestra-4, 14-dien-3-ona y 17-esteres del mismo. |
DE60330749D1 (de) * | 2002-01-21 | 2010-02-11 | Organon Nv | Verfahren zur herstellung von 7-alpha-methylsteroide |
GB0304927D0 (en) * | 2003-03-04 | 2003-04-09 | Resolution Chemicals Ltd | Process for the production of tibolone |
PE20050677A1 (es) | 2003-12-22 | 2005-10-04 | Akzo Nobel Nv | Esteroides con perfil androgenico y progestagenico mixto |
UA89964C2 (ru) | 2004-09-08 | 2010-03-25 | Н.В. Органон | 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ |
CN102227441A (zh) * | 2008-10-15 | 2011-10-26 | 斯索恩有限公司 | 制备氟维司群的方法和中间体 |
WO2012164095A1 (en) * | 2011-06-01 | 2012-12-06 | Estetra S.A. | Process for the production of estetrol intermediates |
SG195118A1 (en) | 2011-06-01 | 2013-12-30 | Estetra S A | Process for the production of estetrol intermediates |
EP2383279A1 (de) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Herstellungsverfahren für Esterol |
SG11201401282PA (en) * | 2011-10-07 | 2014-05-29 | Estetra Sprl | Process for the production of estetrol |
WO2015181116A1 (en) | 2014-05-26 | 2015-12-03 | Crystal Pharma, S.A.U. | Process and intermediades for the preparation of 7-alkylated steroids |
SI3310346T1 (sl) | 2015-06-18 | 2021-07-30 | Estetra Sprl | Orodisperzibilna tableta, ki vsebuje estetrol |
US10894014B2 (en) | 2015-06-18 | 2021-01-19 | Estetra Sprl | Orodispersible tablet containing Estetrol |
PE20231714A1 (es) | 2015-06-18 | 2023-10-23 | Estetra Sprl | Unidad de dosificacion orodispersable que contiene un componente estetrol |
UA123098C2 (uk) | 2015-06-18 | 2021-02-17 | Естетра Спрл | Диспергована у порожнині рота одиниця дозування, що містить естетрольний компонент |
CA3178291A1 (en) | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
ES2906117T3 (es) * | 2017-02-23 | 2022-04-13 | Siemens Healthcare Diagnostics Inc | Conjugados de androstenodiona quimioluminiscente |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA712312B (en) * | 1970-04-28 | 1972-01-26 | Ochsner Med Found Alton | 4,14-estradiene compounds |
-
2000
- 2000-06-27 TW TW089112646A patent/TW548277B/zh not_active IP Right Cessation
- 2000-07-10 SK SK71-2002A patent/SK712002A3/sk unknown
- 2000-07-10 TR TR2002/00076T patent/TR200200076T2/xx unknown
- 2000-07-10 HU HU0201952A patent/HUP0201952A3/hu unknown
- 2000-07-10 CZ CZ2002192A patent/CZ2002192A3/cs unknown
- 2000-07-10 PL PL00353007A patent/PL353007A1/xx not_active IP Right Cessation
- 2000-07-10 KR KR1020027000566A patent/KR20020092890A/ko not_active Application Discontinuation
- 2000-07-10 DE DE60007530T patent/DE60007530T2/de not_active Expired - Fee Related
- 2000-07-10 IL IL14733200A patent/IL147332A0/xx unknown
- 2000-07-10 BR BR0012489-3A patent/BR0012489A/pt not_active IP Right Cessation
- 2000-07-10 WO PCT/EP2000/006544 patent/WO2001005806A1/en not_active Application Discontinuation
- 2000-07-10 EP EP00953032A patent/EP1203011B1/de not_active Expired - Lifetime
- 2000-07-10 NZ NZ516525A patent/NZ516525A/xx unknown
- 2000-07-10 ES ES00953032T patent/ES2213596T3/es not_active Expired - Lifetime
- 2000-07-10 CN CN00810310A patent/CN1360589A/zh active Pending
- 2000-07-10 JP JP2001511464A patent/JP2003505394A/ja not_active Withdrawn
- 2000-07-10 RU RU2002103883/04A patent/RU2002103883A/ru unknown
- 2000-07-10 AU AU65629/00A patent/AU770412B2/en not_active Ceased
- 2000-07-10 MX MXPA02000601A patent/MXPA02000601A/es not_active Application Discontinuation
- 2000-07-10 AT AT00953032T patent/ATE257159T1/de not_active IP Right Cessation
- 2000-07-10 CA CA002379223A patent/CA2379223A1/en not_active Abandoned
- 2000-07-11 US US09/613,350 patent/US6313108B1/en not_active Expired - Fee Related
- 2000-07-13 CO CO00052876A patent/CO5200765A1/es not_active Application Discontinuation
- 2000-07-14 AR ARP000103625A patent/AR024746A1/es not_active Application Discontinuation
- 2000-07-14 PE PE2000000702A patent/PE20010330A1/es not_active Application Discontinuation
-
2001
- 2001-07-31 US US09/918,626 patent/US6541465B2/en not_active Expired - Fee Related
-
2002
- 2002-01-04 ZA ZA200200106A patent/ZA200200106B/xx unknown
- 2002-01-15 NO NO20020222A patent/NO20020222L/no not_active Application Discontinuation
- 2002-07-24 HK HK02105466.2A patent/HK1043797A1/zh unknown
- 2002-10-24 US US10/280,038 patent/US6780854B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200200106B (en) | Orally active androgens. | |
HK1050367A1 (en) | Pharmaceutically active compounds. | |
ZA200000894B (en) | 4-Phenyl-pyridine derivatives. | |
MXPA01013362A (es) | Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso. | |
ZA200201055B (en) | Amino-triazolopyridine derivatives. | |
HK1037453A1 (en) | Earphone. | |
ZA200200477B (en) | 2-pyrazolin-5-ones. | |
EG24361A (en) | 4-pyrimiding1-n-acy1.l.phenlalanines | |
ZA200109595B (en) | 13-methyl-erythromycin derivatives. | |
ZA200202537B (en) | Pour-on-formulations. | |
HK1046411A1 (en) | 5-Phenyl-pyrimidine derivatives. | |
ZA200201829B (en) | New phenylpiperazines. | |
HK1053470A1 (en) | 4-Pyridinyln-acyl-l-phenylalanines. | |
ZA200006352B (en) | Compound napkin. | |
ZA200108968B (en) | New compounds. | |
ZA200110127B (en) | Substituted benzimidazole. | |
HK1047596A1 (en) | 14, 15-Beta-methylene substituted androgens | |
ZA200201276B (en) | 3-Amino-2-phenyl-propane derivatives. | |
MXPA01011285A (es) | Derivados de tio-oxindol. | |
MXPA03000650A (es) | Compuesto farmaceuticamente activo. | |
ZA200204581B (en) | Nitro-sulfobenzamides. | |
HK1031254A1 (en) | Tachogragh. | |
ZA200204604B (en) | Saccharin derivatives as orally active elastase inhibitors. | |
ZA200005361B (en) | Positioning arrangement. | |
ZA200109416B (en) | Crusher. |